Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4592-4599

  Omerovic, Elmir ^a   Bollano, Entela ^a   Mobini, Reza ^a   Kujacic, V U K ^a   Madhu, Basetti ^a   Soussi, Bassam ^a   Michael, F U ^a   Hjalmarson, A K E ^a   Waagstein, Finn ^a   Isgaard, Jörgen ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; CREATINE PHOSPHATE; GROWTH HORMONE; NEUROHORMONE; NORADRENALIN; PHOSPHORUS 31;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CATECHOLAMINE RELEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE METABOLISM; HEART VENTRICLE REMODELING; IN VIVO STUDY; MALE; MORPHOLOGY; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

EID: 17744389575     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7803     Document Type: Article

References (41)

1. Growth hormone improves cardiac performance in experimental heart failure
2. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
3. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
4. Increased mortality associated with growth hormone treatment in critically ill adults
5. Effects of growth hormone and insulin on amino acid transport in perfused rat heart
6. MR spectroscopy of the human heart: The status and the challenges
7. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction
8. Metabolic consequences of coronary stenosis. Transmurally heterogeneous myocardial ischemia studied by spatially localized 31P NMR spectroscopy
9. Bioenergetic, functional and morphologic consequences of postinfarct cardiac remodeling in the rat
10. In vivo 31P nuclear magnetic resonance spectroscopy in patients with old myocardial infarction
11. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure
12. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy
13. Cardiac sympathetic nerve function in congestive heart failure
14. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure
15. Heart failure: Mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention
16. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency
17. Simple technique for the surgical occlusion of coronary vessels in the rat
18. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat
19. Estimation of wall stress and left ventricular mass by noninvasive techniques and clinical implications
20. Non-invasive assessment of ventricular damage in rats with myocardial infarction
21. Correcting human heart 31P NMR spectra fo partial saturation. Evidence that saturation factors for PCr/ATP are homogenous in normal and disease states
22. In vivo activity of tyrosine hydroxylase in rat adrenal glands following administration of quinpirole and dopamine
23. Is cardiac failure a consequence of decreased energy reserve?
24. Disturbed myocardial energy-status correlates with left ventricular systolic and diastolic function
25. The creatine kinase system in normal and diseased human myocardium
26. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction
27. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy
28. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle
29. The effect of growth hormone and thyroxine on the amount of L-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase
30. The regulation of total creatine content in a myoblast cell line
31. Modulation of Pi transport in skeletal muscle by insulin and IGF-1
32. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
33. Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure
34. GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction
35. Sexual dimorphism in the control of growth hormone secretion
36. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency
37. Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy
38. β-Adrenergic pathways in nonfailing and failing human ventricular myocardium
39. Adrenergic effects on the biology of the adult mammalian cardiocyte
40. Myocardial alterations induced by prolonged noradrenaline administration in various doses
41. Parasympathetic muscarinic stimulation limits noradrenalirte induced myocardial creatine kinase release: A study in the isolated perfused working rat heart